Gujarat Kidney & Super Speciality Ltd.
179.46
INR
-4.43
(-2.41%)
ISIN
INE0V0W01025
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Pragnesh Y. Bharpoda
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Vadodara India
- IPO Date
- Dec 30, 2025
- Similar Companies
- Business
- Gujarat Kidney & Super Speciality Ltd. is an India-based healthcare services provider specializing in comprehensive nephrology, urology, renal transplantation, and tertiary super-speciality medical care. Founded and headquartered in Gujarat, India, the company operates multi-speciality hospital facilities and specialized clinical units serving patient populations across western India. The company delivers an integrated spectrum of clinical solutions and healthcare services: nephrology and renal care, including maintenance hemodialysis, peritoneal dialysis, continuous renal replacement therapy, kidney transplantation, and chronic kidney disease management; urology and uro-oncology, encompassing laser lithotripsy, endourology, transurethral surgeries, reconstructive urology, pediatric urology, and minimally invasive laparoscopic procedures; multi-speciality medical care, comprising cardiology, critical care and intensive care management, general and gastrointestinal surgery, internal medicine, and orthopedics; and ancillary healthcare services, consisting of round-the-clock emergency care, 24/7 clinical pathology, biochemistry diagnostics, advanced imaging modalities, in-house pharmacy retail, and post-operative rehabilitation programs. In recent developments, Gujarat Kidney & Super Speciality Ltd. successfully completed its initial public offering and listing on the National Stock Exchange of India (NSE: GKSL) to finance institutional expansion, upgraded its critical care infrastructure with enhanced inpatient bed capacity, integrated advanced laser and endoscopic surgical platforms, and broadened its clinical outreach through new satellite dialysis centers and specialized outpatient clinics across regional healthcare markets.